Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations.
Mol Genet Metab. 1999 Dec;68(4):419-23. doi: 10.1006/mgme.1999.2942.
Mol Genet Metab. 1999.
PMID: 10607471
Review.